期刊文献+

1例支气管扩张合并糖尿病、痛风患者的药学监护

Pharmaceutical care on a patient with bronchiectasis,diabetes and gout
下载PDF
导出
摘要 目的通过分析1例支气管扩张合并糖尿病、痛风患者的药学监护过程,探讨基层医院临床药师实行药学监护的切入点。方法临床药师根据患者肾脏功能和过敏史,调整选用的抗菌药物,通过计算调整药品剂量、有针对性地选择抗痛风药物等为患者提供药学服务。结果医师采纳药师用药建议,患者没有出现药品不良反应,病情得到缓解。结论临床药师对患者进行药学监护,完善了临床治疗方案,提高了患者用药的安全性和有效性。 Objective To explore the breakthrough point of pharmaceutical care for a patient with bronchiectasis,diabetes and gout. Methods The clinical pharmacist recommended appropriate antibiotics and gout medications. The dosage and therapy regimen were optimized based on the patient's renal function, allergy and disease history. Results The physician accepted the suggestions from clinical pharmacists. The patient recovered well with no adverse drug reactions. Conclusion With the knowledge of clinical pharmacist, clinical treatment plan was optimized. The patient received better pharmaceutical care.
作者 曹琴 李昱柳 CAO Qin LI Yuliu(Department of Pharmacy,8690 of Chinese People's Armed Police Forces Hospital,Yixing 214205,China)
机构地区 武警
出处 《药学实践杂志》 CAS 2017年第2期171-173,共3页 Journal of Pharmaceutical Practice
基金 浙江省医学会临床科研基金(2013ZYC-A08)
关键词 药学监护 支气管扩张 糖尿病 痛风 pharmaceutical care bronchiectasis diabetes gout
  • 相关文献

参考文献3

二级参考文献79

  • 1Woodhead M, Blasi F, Ewig S, et al. European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J,2005,26 : 1138-1180.
  • 2Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections - - full version. Clin Microbiol Infect, 2011, 17 Suppl 6: El-E59.
  • 3Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax,2010,65 Suppl 1 :i1- 58.
  • 4Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Am J Respir Cfit Care Med, 2004,169 : A330.
  • 5Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child,2005, 90:737-740.
  • 6Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Clin Pulm M ed,2005,12:205- 209.
  • 7Crofton J. Bronchiectasis. In: Cmflon J, Douglas A, eds. Respiratory diseases. 3 rd eds. Oxford: Blackwell Scientific, 1981:417-430.
  • 8Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004,70 : 400- 407.
  • 9O'Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax, 2000,55 : 635-642.
  • 10King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis, 2009,4 : 411-419.

共引文献491

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部